Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
125.19
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
26
Open
125.19
Bid (Size)
125.19 (800)
Ask (Size)
125.69 (100)
Prev. Close
125.19
Today's Range
125.19 - 125.19
52wk Range
88.57 - 128.70
Shares Outstanding
1,253,809,440
Dividend Yield
2.52%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
These S&P500 stocks are moving in today's session
↗
December 23, 2025
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via
Chartmill
Performance
YTD
+36.3%
+36.3%
1 Month
-0.1%
-0.1%
3 Month
+9.4%
+9.4%
6 Month
+16.8%
+16.8%
1 Year
+34.0%
+34.0%
More News
Read More
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs
↗
December 22, 2025
Via
Stocktwits
Gilead Sciences to Present at Upcoming Investor Conference
December 22, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes
↗
December 22, 2025
Via
Benzinga
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 22, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
↗
December 20, 2025
Via
Benzinga
Topics
Government
Why Gilead Sciences (GILD) Stock Is Up Today
December 19, 2025
Via
StockStory
Topics
Earnings
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants
↗
December 19, 2025
Via
Stocktwits
Topics
Government
World Trade
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump
↗
December 19, 2025
Via
Investor's Business Daily
Topics
Government
Stocks
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 19, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Inc. (NASDAQ:GILD): A High-Quality Dividend Stock for Reliable Income
↗
December 19, 2025
Via
Chartmill
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report
↗
December 19, 2025
Via
Stocktwits
Topics
Economy
Government
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
December 18, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks
↗
December 17, 2025
Via
Stocktwits
Topics
Government
World Trade
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
↗
December 17, 2025
Via
Benzinga
Gilead's Experimental Combo Tablet For HIV Treatment Hits Primary Goal
↗
December 15, 2025
Via
Benzinga
3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains
↗
December 15, 2025
Via
MarketBeat
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
December 15, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
Why Arcus Biosciences Just Reversed Its 287% Eight-Month Winning Streak
↗
December 12, 2025
Via
Investor's Business Daily
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
December 12, 2025
From
Equity Insider
Via
GlobeNewswire
Gilead Sciences Inc. (NASDAQ:GILD) Presents a Compelling Profile for Value Investors
↗
December 12, 2025
Via
Chartmill
3 Profitable Stocks We Keep Off Our Radar
December 10, 2025
Via
StockStory
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
December 09, 2025
From
Gilead Sciences, Inc.
Via
Business Wire
What Does the Market Think About Gilead Sciences Inc?
↗
December 08, 2025
Via
Benzinga
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 125.19
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 12/23/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 156.96B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 157B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.